Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Patient-partnership in a comprehensive cancer centre: Establishment and roles of a patients and caregivers committee].
De Jesus A, Faveur A, Garnier L, Servant C, Le Bars S, Cousin G, Dagorne P, De La Rocque F, Delgrange S, Guidy C, Manighetti J, Roux R, Sazy T, Scull I, Terrade C, Turkel L, Veret F, Escudier B, Billard C, Rieutord A, Khoury J, Blot F. De Jesus A, et al. Among authors: roux r. Bull Cancer. 2024 Apr 24:S0007-4551(24)00116-4. doi: 10.1016/j.bulcan.2024.02.010. Online ahead of print. Bull Cancer. 2024. PMID: 38664089 French.
Towards the understanding of the uptake and depuration of microplastics in the ragworm Hediste diversicolor: Field and laboratory study.
Revel M, Freund C, Mouloud M, Perrein-Ettajani H, Métais I, Bruneau M, Yakovenko N, Le Roux R, Caley T, Alogbleto W, Verrier V, Dreanno C, El Rakwe M, Châtel A. Revel M, et al. Among authors: le roux r. Mar Environ Res. 2024 Apr;196:106410. doi: 10.1016/j.marenvres.2024.106410. Epub 2024 Feb 16. Mar Environ Res. 2024. PMID: 38422819
Results of a randomised Phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancer.
Nicum S, McGregor N, Austin R, Collins L, Dutton S, McNeish I, Glasspool R, Hall M, Roux R, Michael A, Clamp A, Jayson G, Kristeleit R, Banerjee S, Mansouri A. Nicum S, et al. Among authors: roux r. Br J Cancer. 2024 Apr;130(6):941-950. doi: 10.1038/s41416-023-02567-6. Epub 2024 Jan 20. Br J Cancer. 2024. PMID: 38245661 Free PMC article. Clinical Trial.
The clinicopathological characteristics and survival outcomes of primary expansile vs. infiltrative mucinous ovarian adenocarcinoma: a retrospective study sharing the experience of a tertiary centre.
Nistor S, El-Tawab S, Wong F, Zouridis A, Roux R, Manek S, Gaitskell K, Ahmed AA, Kehoe S, Soleymani Majd H. Nistor S, et al. Among authors: roux r. Transl Cancer Res. 2023 Oct 31;12(10):2682-2692. doi: 10.21037/tcr-23-863. Epub 2023 Oct 24. Transl Cancer Res. 2023. PMID: 37969399 Free PMC article.
A population-scale temporal case-control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP).
Starkey T, Ionescu MC, Tilby M, Little M, Burke E, Fittall MW, Khan S, Liu JKH, Platt JR, Mew R, Tripathy AR, Watts I, Williams ST, Appanna N, Al-Hajji Y, Barnard M, Benny L, Burnett A, Bytyci J, Cattell EL, Cheng V, Clark JJ, Eastlake L, Gerrand K, Ghafoor Q, Grumett S, Harper-Wynne C, Kahn R, Lee AJX, Lomas O, Lydon A, Mckenzie H; NCRI Consumer Forum; Panneerselvam H, Pascoe JS, Patel G, Patel V, Potter VA, Randle A, Rigg AS, Robinson TM, Roylance R, Roques TW, Rozmanowski S, Roux RL, Shah K, Sheehan R, Sintler M, Swarup S, Taylor H, Tillett T, Tuthill M, Williams S, Ying Y, Beggs A, Iveson T, Lee SM, Middleton G, Middleton M, Protheroe A, Fowler T, Johnson P, Lee LYW. Starkey T, et al. Among authors: roux rl. Sci Rep. 2023 Jul 25;13(1):11327. doi: 10.1038/s41598-023-36990-9. Sci Rep. 2023. PMID: 37491478 Free PMC article.
92 results